Skip to Content

Kabiven Approval History

  • FDA approved: Yes (First approved August 25th, 2014)
  • Brand name: Kabiven
  • Generic name: amino acids, electrolytes, dextrose and lipid
  • Dosage form: Injectable Emulsion
  • Company: Fresenius Kabi USA, LLC
  • Treatment for: Parenteral Nutrition

Kabiven (amino acids, electrolytes, dextrose and lipid injectable emulsion) is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition.

Development History and FDA Approval Process for Kabiven

DateArticle
Aug 27, 2014Approval Fresenius Kabi Receives FDA Approval for Kabiven and Perikabiven

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide